|
CHAC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.24120000522777E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.5843999979821E-08 |
| Normal-vs-Stage2 |
3.79490000002036E-06 |
| Normal-vs-Stage3 |
2.592200E-01 |
| Normal-vs-Stage4 |
4.830400E-01 |
| Stage1-vs-Stage2 |
7.260200E-01 |
| Stage1-vs-Stage3 |
1.995520E-02 |
| Stage1-vs-Stage4 |
7.556100E-02 |
| Stage2-vs-Stage3 |
4.674400E-02 |
| Stage2-vs-Stage4 |
4.394100E-02 |
| Stage3-vs-Stage4 |
8.943800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.80049999751486E-09 |
| Normal-vs-AfricanAmerican |
8.124700E-03 |
| Normal-vs-Asian |
5.858600E-01 |
| Caucasian-vs-AfricanAmerican |
1.194600E-01 |
| Caucasian-vs-Asian |
1.377390E-03 |
| AfricanAmerican-vs-Asian |
1.370790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02700004056544E-09 |
| Normal-vs-Female |
9.378500E-02 |
| Male-vs-Female |
4.165700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.408600E-04 |
| Normal-vs-Extreme_Weight |
7.03049840566905E-11 |
| Normal-vs-Obese |
3.78540000000038E-05 |
| Normal-vs-Extreme_Obese |
4.199600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.639200E-01 |
| Normal_Weight-vs-Obese |
8.569200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.621000E-01 |
| Extreme_Weight-vs-Obese |
2.576600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.223000E-01 |
| Obese-vs-Extreme_Obese |
7.136000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.165600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.22649999992441E-07 |
| Normal-vs-Age(61-80Yrs) |
9.79690000235678E-08 |
| Normal-vs-Age(81-100Yrs) |
2.1792000000076E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.513900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.034200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.901900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.203200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.037400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.965410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.96900290411395E-11 |
| Normal-VS-Type2 PRCC |
3.015700E-04 |
| Normal-VS-KIRP CIMP |
3.039900E-02 |
| Normal-VS-Unclassified PRCC |
3.386600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.612000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.562500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.278400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.56749999999618E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.780600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.91536999999409E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31290000005002E-06 |
| Normal-vs-N1 |
8.067800E-01 |
| Normal-vs-N2 |
5.666600E-01 |
| N0-vs-N1 |
8.036800E-03 |
| N0-vs-N2 |
4.939000E-01 |
| N1-vs-N2 |
4.733200E-01 |
|
|
